FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322630671> ?p ?o ?g. }

• W4322630671 abstract "Background: Colon adenocarcinoma (COAD) is a heterogeneous tumor and senescence is crucial in the occurrence of cancer. This study aimed to identify senescence-based subtypes and construct a prognostic signature to predict the prognosis and guide immunotherapy or chemotherapy decisions for COAD patients. Methods: Based on the single-cell RNA sequencing (scRNA-seq) data of 13 samples from the Gene Expression Omnibus (GEO) database, we assessed cellular senescence characteristics. Transcriptome data, copy number variations (CNVs) and single nucleotide variations (SNVs) data were obtained from The Cancer Genome Atlas (TCGA) database. GSE39582 and GSE17537 were used for validation. Senescence subtypes were identified using unsupervised consensus clustering analysis, and a prognostic signature was developed using univariate Cox analysis and least absolute shrinkage and selection operator (LASSO). Response of risk groups to chemotherapy was predicted using the half-maximal inhibitory concentration (IC50) values. We further analyzed the relationship between risk gene expression and methylation level. The prediction performance was assessed by nomogram. Results: Senescence-related pathways were highly enriched in malignant cells and bulk RNA-seq verified cellular senescence. Three senescence subtypes were identified, in which patients in clust3 had poorest prognosis and higher T stage, accompanied with higher tumor mutation burden (TMB) and mutations, activated inflammatory response, more immune cell infiltration, and higher immune escape tendency. A senescence-based signature using 11 genes (MFNG, GPRC5B, TNNT1, CCL22, NOXA1, PABPC1L, PCOLCE2, MID2, CPA3, HSPA1A, and CALB1) was established, and accurately predicted a lower prognosis in high risk patients. Its robustness was validated by external cohort. Low risk patients were more sensitive to small molecule drugs including Erlotinib, Sunitinib, MG-132, CGP-082996, AZ628, Sorafenib, VX-680, and Z-LLNle-CHO. Risk score was an independent prognostic factor and nomogram confirmed its reliability. Four risk genes (CALB1, CPA3, NOXA1, and TNNT1) had significant positive correlation with their methylation level, while six genes (CCL22, GPRC5B, HSPA1A, MFNG, PABPC1L, and PCOLCE2) were negatively correlated with their methylation level. Conclusion: This study provides novel understanding of heterogeneity in COAD from the perspective of senescence, and develops signatures for prognosis prediction in COAD." @default.
• W4322630671 created "2023-03-01" @default.
• W4322630671 creator A5022656945 @default.
• W4322630671 creator A5037811757 @default.
• W4322630671 creator A5080177287 @default.
• W4322630671 date "2023-02-28" @default.
• W4322630671 modified "2023-10-16" @default.
• W4322630671 title "Comprehensive genomics analysis of aging related gene signature to predict the prognosis and drug resistance of colon adenocarcinoma" @default.
• W4322630671 cites W1540089290 @default.
• W4322630671 cites W1975528145 @default.
• W4322630671 cites W1982481909 @default.
• W4322630671 cites W2035618305 @default.
• W4322630671 cites W2097177355 @default.
• W4322630671 cites W2146512944 @default.
• W4322630671 cites W2151506973 @default.
• W4322630671 cites W2154941270 @default.
• W4322630671 cites W2159707944 @default.
• W4322630671 cites W2546466212 @default.
• W4322630671 cites W2560375214 @default.
• W4322630671 cites W2605230952 @default.
• W4322630671 cites W2743416243 @default.
• W4322630671 cites W2757008523 @default.
• W4322630671 cites W2788548733 @default.
• W4322630671 cites W2791666691 @default.
• W4322630671 cites W2796153225 @default.
• W4322630671 cites W2885591122 @default.
• W4322630671 cites W2886498337 @default.
• W4322630671 cites W2896872272 @default.
• W4322630671 cites W2898415660 @default.
• W4322630671 cites W2911865536 @default.
• W4322630671 cites W2942910249 @default.
• W4322630671 cites W2949273159 @default.
• W4322630671 cites W2950467198 @default.
• W4322630671 cites W2982307680 @default.
• W4322630671 cites W3005127469 @default.
• W4322630671 cites W3019755975 @default.
• W4322630671 cites W3045897752 @default.
• W4322630671 cites W3087148837 @default.
• W4322630671 cites W3120431660 @default.
• W4322630671 cites W3123988232 @default.
• W4322630671 cites W3134393894 @default.
• W4322630671 cites W3155082085 @default.
• W4322630671 cites W3173096526 @default.
• W4322630671 cites W3178723556 @default.
• W4322630671 cites W3205925078 @default.
• W4322630671 cites W3212670168 @default.
• W4322630671 cites W3215350912 @default.
• W4322630671 cites W4210433744 @default.
• W4322630671 cites W4214539922 @default.
• W4322630671 cites W4281684148 @default.
• W4322630671 cites W4282834204 @default.
• W4322630671 cites W4283269867 @default.
• W4322630671 cites W4285088313 @default.
• W4322630671 cites W4288535500 @default.
• W4322630671 cites W4289839218 @default.
• W4322630671 cites W4290702585 @default.
• W4322630671 cites W4292336398 @default.
• W4322630671 cites W4292582804 @default.
• W4322630671 cites W4294992927 @default.
• W4322630671 cites W4295815928 @default.
• W4322630671 cites W4304842977 @default.
• W4322630671 cites W4307115337 @default.
• W4322630671 cites W4313250083 @default.
• W4322630671 doi "https://doi.org/10.3389/fphar.2023.1121634" @default.
• W4322630671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36925638" @default.
• W4322630671 hasPublicationYear "2023" @default.
• W4322630671 type Work @default.
• W4322630671 citedByCount "0" @default.
• W4322630671 crossrefType "journal-article" @default.
• W4322630671 hasAuthorship W4322630671A5022656945 @default.
• W4322630671 hasAuthorship W4322630671A5037811757 @default.
• W4322630671 hasAuthorship W4322630671A5080177287 @default.
• W4322630671 hasBestOaLocation W43226306711 @default.
• W4322630671 hasConcept C104317684 @default.
• W4322630671 hasConcept C120821319 @default.
• W4322630671 hasConcept C121608353 @default.
• W4322630671 hasConcept C141231307 @default.
• W4322630671 hasConcept C143998085 @default.
• W4322630671 hasConcept C150194340 @default.
• W4322630671 hasConcept C162317418 @default.
• W4322630671 hasConcept C2779733811 @default.
• W4322630671 hasConcept C502942594 @default.
• W4322630671 hasConcept C522857546 @default.
• W4322630671 hasConcept C526805850 @default.
• W4322630671 hasConcept C54355233 @default.
• W4322630671 hasConcept C60644358 @default.
• W4322630671 hasConcept C71924100 @default.
• W4322630671 hasConcept C86803240 @default.
• W4322630671 hasConceptScore W4322630671C104317684 @default.
• W4322630671 hasConceptScore W4322630671C120821319 @default.
• W4322630671 hasConceptScore W4322630671C121608353 @default.
• W4322630671 hasConceptScore W4322630671C141231307 @default.
• W4322630671 hasConceptScore W4322630671C143998085 @default.
• W4322630671 hasConceptScore W4322630671C150194340 @default.
• W4322630671 hasConceptScore W4322630671C162317418 @default.
• W4322630671 hasConceptScore W4322630671C2779733811 @default.
• W4322630671 hasConceptScore W4322630671C502942594 @default.
• W4322630671 hasConceptScore W4322630671C522857546 @default.
• W4322630671 hasConceptScore W4322630671C526805850 @default.
• W4322630671 hasConceptScore W4322630671C54355233 @default.

• next